Thank you, Eyal. As previously mentioned by Ofer, in July, we successfully concluded a fundraising round securing total gross proceeds of $8,500,000 I must emphasize that the securities issued in this round were common stock only, which did not include any warrant coverage. As of June 30, 2023, EverGen has consolidated cash, cash equivalents and short term bank deposits of approximately $33,900,000 Of good sum, Bionica accounted for $16,800,000 and Yavri Bio holds $7,100,000 Pembagen, together with Costera Economic and AgPlanet, possessed an aggregate of $10,000,000 in cash. The injection of funds from this last round in July strengthens Evident's financial position and provides us with the resources needed to execute our future plans effectively and in a timely fashion. An example of such financial need is significant increase in the required working capital of our own subsidiary, Castera, in order to produce the customer fees needed to fulfill purchase orders received in the last month, totaling $11,300,000 It is important to note that the $10,000,000 reflected in the cash balance of Evogene, together with Castello, Canonic and AgPlanist, do not include funds raised by Evogene in July and any amount due to the purchase order received by Castera in the last few months, which are expected to be supplied during the second half of the year and at the beginning of next year.
